Mesaneye Metastaz Yapan Tümörler

Efesoy O, Cayan S. Bladder metastasis of malignant melanoma: a case report and review of literature. Med Oncol. 2011 Dec;28 Suppl 1:S667-9. doi: 10.1007/s12032-010-9730-x. Epub 2010 Nov 2. PMID: 21042956.

Bates AW, Baithun SI. Secondary neoplasms of the bladder are histological mimics of nontran- sitional cell primary tumours: clinicopathologi- cal and histological features of 282 cases. His- topathology 2000; 36: 32-40.

Velcheti V, Govindan R. Metastatic cancer in- volving bladder: a review. Can J Urol 2007; 14: 3443-3448.

Michels J, Barbour S, Cavers D, Chi KN. Meta- static signet-ring cell cancer of the bladder re- sponding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J 2010; 4: E55-E57.

Mai KT, Ford JC, Morash C, Gerridzen R. Primary and secondary prostatic adenocarcinoma of the urinary bladder. Hum Pathol. 2001 Apr;32(4):434-40. doi: 10.1053/hupa.2001.23518. PMID: 11331961.

Conolly JA, Shinohara K, Presti JC Jr, et al: Local recurrence after radical prostatectomy: Characteristics in size, location, and re- lationship to prostatic-specific antigen and surgical margins. Urology 47:225-231, 1996

Imanaka T, Yoshida T, Wakita T, Yoshimura A, Yamanaka K, Kishikawa H. Metastatic bladder tumor from prostate cancer causing a ball valve-like obstruction in urination. Urol Case Rep. 2020 Sep 2;33:101398. doi: 10.1016/j.eucr.2020.101398. PMID: 33102096; PMCID: PMC7574048.

Pramod KS, Mukesh KV, Ranjit KD, Uttara C. Secondary signet-ring cell adenocarcinoma of urinary bladder from a gastric primary. Urol Ann 2011, 3:97–99.

Valero PJA, Medina PM, García CM, Valpuesta FI, Sánchez GM, Mompean FO. Bladder metastasis of signet-ring cell adenocarcinoma from the stomach. Arch Esp Urol 2000, 53:839–834.

András C, Tóth L, Pósán J, Csiki E, Tanyi M, Csiki Z, Garami Z, Enyedi A, Flaskó T, Horváth Z. Occurrence of bladder metastasis 10 years after surgical removal of a primary gastric cancer: a case report and review of the literature. J Med Case Rep. 2013 Aug 14;7:204. doi: 10.1186/1752-1947-7-204.

Kalra S, Manikandan R, Dorairajan LN, Badhe B. Synchronously detected secondary signet ring cell urinary bladder malignancy from the stomach masquerading as genitourinary tuberculosis. BMJ Case Rep. 2015 Jan 23;2015:bcr2014206120. doi: 10.1136/bcr-2014-206120. PMID: 25618874; PMCID:

Mostofi FK, Thompson RV, Dean AL. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955;8:741–58.

Sharma PK, Vijay MK, Das RK, Chatterjee U. Secondary signet-ring cell adenocarcinoma of urinary bladder from a gastric primary. Urol Ann. 2011 May;3(2):97-9. doi: 10.4103/0974-7796.82177. PMID: 21747602; PMCID: PMC3130488.

Gopalan A, Sharp DS, Fine SW, Tickoo SK, Herr HW, Reuter VE, Olgac S. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009; 33: 659-668.

Lin F, Liu H. Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. Arch Pathol Lab Med 2014; 138: 1583-1610.

Marques ML, D’Alessandro GS, Chade DC, Lanzoni VP, Saiovici S, Almeida CJ. Primary mu- cinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J 2007; 125: 297-299.

Rao Q, Williamson SR, Lopez-Beltran A, Mon- tironi R, Huang W, Eble JN, Grignon DJ, Koch MO, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Cheng L. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol 2013; 26: 725-732. 18- Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV. Primary bladder adenocarci- noma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol 2012; 7: 151.

Kobayashi T, Kamoto T, Sugino Y, Takeuchi H, Habuchi T, Ogawa O. High incidence of urinary bladder involvement in car- cinomas of the sigmoid and rectum: a retrospective review of 580 patients with colorectal carcinoma. J Surg Oncol 2003;84: 209–14.

Giuliani A, Galati G, Demoro M, Scimò M, Ciardi A, Basso L. Endoluminal metastasis of colon cancer to the urinary bladder via the ureter: report of a case. Surg Today. 2010 Nov;40(11):1093-6. doi: 10.1007/s00595-009-4192-5. Epub 2010 Nov 3. PMID: 21046512.

Lee CS, et al. Management of metastatic malignant melanoma of the bladder. Urology. 2003;62:35xi–35xiii.

Menendez Lopez V, Alvarez-Vijande Garcia R, Sole Arques M, Carretero Gonzalez P. Bladder metastasis of malignant mela- noma: report of a case. Arch Esp Urol. 2002;55:1277–9.

Demirkesen O, Yaycioglu O, Uygun N, Demir G, Yalcin V. A case of metastatic malignant melanoma presenting with hematuria. Urol Int. 2000;64:118–20.

Arapantoni-Dadioti P, Panayiotides J, Kalkandi P, Christodoulou C, Delides GS. Metastasis of malignant melanoma to a transitional cell carcinoma of the bladder. Eur J Surg Oncol. 1995;21: 92–3.

Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull. 1995;51:609–30.

Topal CS, Kır G, Daş T, Sarbay B, Tosun Mİ. Metastatic malignant melanoma of the urinary bladder: A case report and review of the literature. Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):532-534. doi: 10.4103/0377-4929.191820. PMID: 27721291.

Acquavella N, et al. Toxicity and activity of a twice daily high- dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J Immunother. 2008; 31:569–76.

Soon PS, Lynch W, Schwartz P. Breast cancer presenting initially with urinary incontinence: a case of bladder metastasis from breast cancer. Breast. 2004 Feb;13(1):69-71. doi: 10.1016/j.breast.2003.09.005. PMID: 14759720.

Feldman PA, Madeb R, Naroditsky I, Halachmi S, Nativ O. Metastatic breast cancer to the bladder: a diagnostic challenge and review of the literature. Urology 2002; 59: 138.

Borhan WM, Cimino-Mathews AM, Montgom- ery EA, Epstein JI. Immunohistochemical differ- entiation of plasmacytoid urothelial carcinoma from secondary carcinoma involvement of the bladder. Am J Surg Pathol 2017; 41: 1570- 1575.

Massoud W, Ferlicot S, Hajj P, Awad A, Iaaza LA, Hammoudi Y, Droupy S, Benoît G. Metastatic breast carcinoma to the bladder. Urology. 2009 Oct;74(4):785-6. doi: 10.1016/j.urology.2009.02.008. Epub 2009 Jul 22. PMID: 19628272.

Zhang M, Wah C, Epstein JI. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases. Am J Surg Pathol. 2014 Nov;38(11):1516-21. doi: 10.1097/PAS.0000000000000257. PMID: 25140895.

Kava BR, Eldefrawy A, Ayyathurai R, et al. Renal cell carcinoma with solitary metastasis to the bladder: mode of spread and prognosis. Can J Urol. 2012;19:6121–6123.

Doo SW, Kim WB, Kim BK, et al. Metastasis of renal cell carcinoma to the bladder. Korean J Urol. 2013;54:69–72.

Oliva E, Young RH. Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases. Mod Pathol. 1996;9: 513–520.

Modh RA, Corbyons KA, Yeung LL. A rare metastasis to the bladder. Case Rep Urol. 2013;2013:789039. doi: 10.1155/2013/789039. Epub 2013 Mar 3. PMID: 23533933; PMCID: PMC3603616.

Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009;36:8-37.

Raymond KW, Hin TS, Fai KC, Steve CW. Urinary bladder metastasis from lung adenocarcinoma: A rare cause of hematuria. Urol Ann. 2014 Oct;6(4):359-62. doi: 10.4103/0974-7796.141006. PMID: 25371617; PMCID: PMC4216546.

Esheba GE, Longacre TA, Atkins KA, Higgins JP. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Am J Surg Pathol 2009; 33: 347-353.

Liu H, Shi J, Prichard JW, Gong Y, Lin F. Immu- nohistochemical evaluation of GATA-3 expres- sion in ER-negative breast carcinomas. Am J Clin Pathol 2014; 141: 648-655.

Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 im munohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012; 36: 1472-1476.

Miettinen M, Mccue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszc- zyk P, Biernat W, Lasota J, Wang Z. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 2014; 38: 13-22.

Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Aron M, Luthringer DJ, De Peralta-Venturina M, Cho Y, Amin MB. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of vari ants of urothelial carcinoma of the urinary bladder. Hum Pathol 2014; 45: 1473-1482